Clinical and laboratory findings of patients with polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis
| . | Polycythemia vera, n = 54 . | Essential thrombocythemia, n = 44 . | Idiopathic myelofibrosis, n = 12 . |
|---|---|---|---|
| Males/females | 37/17 | 14/30 | 8/4 |
| Age, y, mean | 54 | 55 | 66 |
| Median, range | 54 (24-83) | 56 (20-84) | 65 (57-79) |
| WBC, × 109/L, mean | 11.00 | 9.59 | 7.4 |
| Median, range | 9.8 (5.40-31.92) | 10.06 (4.35-15.12) | 6.61 (3.94-13.8) |
| Hb, g/dL, mean | 16.7 | 13.8 | 9 |
| Median, range | 17 (12.8-21.4) | 13.9 (11-16.4) | 7.8 (6.8-13.4) |
| Hct, %, mean | 52.3 | 43.1 | 27.4 |
| Median, range | 51.2 (38.9-66.1) | 42.7 (33.3-50.3) | 25.6 (19.4-40.2) |
| PLT, × 109/L, mean | 425 | 838 | 445 |
| Median, range | 377 (166-901) | 885 (403-1.484) | 456 (50-1.284) |
| Thrombosis, % | 17 (31) | 11 (25) | 3 (25) |
| . | Polycythemia vera, n = 54 . | Essential thrombocythemia, n = 44 . | Idiopathic myelofibrosis, n = 12 . |
|---|---|---|---|
| Males/females | 37/17 | 14/30 | 8/4 |
| Age, y, mean | 54 | 55 | 66 |
| Median, range | 54 (24-83) | 56 (20-84) | 65 (57-79) |
| WBC, × 109/L, mean | 11.00 | 9.59 | 7.4 |
| Median, range | 9.8 (5.40-31.92) | 10.06 (4.35-15.12) | 6.61 (3.94-13.8) |
| Hb, g/dL, mean | 16.7 | 13.8 | 9 |
| Median, range | 17 (12.8-21.4) | 13.9 (11-16.4) | 7.8 (6.8-13.4) |
| Hct, %, mean | 52.3 | 43.1 | 27.4 |
| Median, range | 51.2 (38.9-66.1) | 42.7 (33.3-50.3) | 25.6 (19.4-40.2) |
| PLT, × 109/L, mean | 425 | 838 | 445 |
| Median, range | 377 (166-901) | 885 (403-1.484) | 456 (50-1.284) |
| Thrombosis, % | 17 (31) | 11 (25) | 3 (25) |